No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Whisker Sells One Millionth Robot and Completes Its $10M USA Manufacturing Expansion

The Global Leader in Connected Pet Care Continues Unprecedented Growth as it Maintains Laser Focus on Developing Best-in-Class, Solution-Oriented Pet Products

Editor: What To Know

  • “As the global leader in connected pet care and the inventors of the best selling automatic globe-sifting litter box, Litter-Robot,, we take great pride in leading the smart pet tech category to transform cat parenthood for the better, and the sale of our millionth robot is just the start to Whisker doing just that,” said Whisker President and CEO, Jacob Zuppke.
  • Whisker, the international leader in connected pet care for the past 22 years, sold its millionth Robot (Litter-Robot and Feeder-Robot) in December, marking a major milestone for the company as it continues to develop new technologies to solve pain points for today's pet parents.
  • As the leading innovator within the pet care and pet tech space, the Whisker Team proudly designs, engineers and assembles its pet robot appliances in the USA, providing beautiful, solution-oriented products to make pet parenting more enjoyable.

Whisker, the international leader in connected pet care for the past 22 years, sold its millionth Robot (Litter-Robot and Feeder-Robot) in December, marking a major milestone for the company as it continues to develop new technologies to solve pain points for today’s pet parents. The landmark sale culminates several years of remarkable growth for the brand.

This year alone, the brand launched the latest Litter-Robot iteration, Litter-Robot 4, completed a $10-million investment in U.S. warehouse expansions in Juneau, Wisconsin, and grew its team to over 400 US-based employees with 40+ engineers.

As the leading innovator within the pet care and pet tech space, the Whisker Team proudly designs, engineers and assembles its pet robot appliances in the USA, providing beautiful, solution-oriented products to make pet parenting more enjoyable. Every product is carefully developed and undergoes rigorous testing to meet the high standards of cats and pet parents alike.

The Litter-Robot 4 was meticulously designed by the Whisker Team, taking more than 20 years of product innovation and experience into consideration. Key features of the latest self-cleaning litter box include its patented connected app, health-monitoring technology, and yet another evolution of the brand’s patented litter-sifting mechanism, among additional features that enhance the cat care experience. Since launching in May, Litter-Robot 4 sales have exceeded expectations and generated glowing reviews from press including recognition from TIME Magazine, Wall Street Journal and more. The company’s impressive growth trajectory over the past 5 years was also featured in a profile and daily cover in Forbes in the last month.

“As the global leader in connected pet care and the inventors of the best selling automatic globe-sifting litter box, Litter-Robot,, we take great pride in leading the smart pet tech category to transform cat parenthood for the better, and the sale of our millionth robot is just the start to Whisker doing just that,” said Whisker President and CEO, Jacob Zuppke. “As we reflect on the success of the past several years, including our recent $10M investment to expand our U.S. based manufacturing facility, we’re eager to build on this continued momentum and further enhance the pet and pet parenting experience across the globe.”

This June, Whisker completed its $10 million investment to expand its U.S. manufacturing facility in Juneau, Wisconsin, further demonstrating the brand’s commitment to domestic manufacturing. The opening of the impressive 162,500 square foot facility allowed for the creation of 100+ new jobs, with an expected 200 more in the next two years. The new facility will allow Whisker to continue leading the pet tech industry in both quality and design – guaranteeing Litter-Robot, Feeder-Robot and Litterbox.com customers the best and most ethically-made pet care products here in the USA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy